{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T19:23:27Z","timestamp":1761765807430},"reference-count":27,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2014,9,1]],"date-time":"2014-09-01T00:00:00Z","timestamp":1409529600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,4,3]],"date-time":"2014-04-03T00:00:00Z","timestamp":1396483200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Brazilian Journal of Infectious Diseases"],"published-print":{"date-parts":[[2014,9]]},"DOI":"10.1016\/j.bjid.2014.01.008","type":"journal-article","created":{"date-parts":[[2014,4,13]],"date-time":"2014-04-13T09:45:17Z","timestamp":1397382317000},"page":"512-517","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Pharmacodynamic profiling of commonly prescribed antimicrobial drugs against Escherichia coli isolates from urinary tract"],"prefix":"10.1016","volume":"18","author":[{"given":"Gabriel Trova","family":"Cuba","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio Carlos Campos","family":"Pignatari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katya Silva","family":"Patekoski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucimila Jorge","family":"Luchesi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos Roberto Veiga","family":"Kiffer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"Suppl 1A","key":"10.1016\/j.bjid.2014.01.008_bib0005","first-page":"5S","article-title":"Epidemiology of urinary tract infections: incidence, morbidity, and economic costs","volume":"113","author":"Foxman","year":"2003","journal-title":"Am J Med"},{"key":"10.1016\/j.bjid.2014.01.008_bib0010","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1086\/519268","article-title":"Population-based epidemiologic analysis of acute pyelonephritis","volume":"43","author":"Czaja","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.bjid.2014.01.008_bib0015","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.2165\/00019053-200523110-00005","article-title":"Acute pyelonephritis among adults: cost of illness and considerations for the economic evaluation of therapy","volume":"23","author":"Brown","year":"2005","journal-title":"Pharmacoeconomics"},{"key":"10.1016\/j.bjid.2014.01.008_bib0020","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/S1047-2797(02)00272-7","article-title":"Acute pyelonephritis in US hospitals in 1997: hospitalization and in-hospital mortality","volume":"13","author":"Foxman","year":"2003","journal-title":"Ann Epidemiol"},{"key":"10.1016\/j.bjid.2014.01.008_bib0025","doi-asserted-by":"crossref","first-page":"e103","DOI":"10.1093\/cid\/ciq257","article-title":"International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: a 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases","volume":"52","author":"Gupta","year":"2011","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.bjid.2014.01.008_bib0030","doi-asserted-by":"crossref","first-page":"41","DOI":"10.7326\/0003-4819-135-1-200107030-00012","article-title":"Increasing antimicrobial resistance and the management of uncomplicated community-acquired urinary tract infections","volume":"135","author":"Gupta","year":"2001","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.bjid.2014.01.008_bib0035","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1007\/s10156-003-0279-X","article-title":"Optimizing outcomes with antimicrobial therapy through pharmacodynamic profiling","volume":"9","author":"Nicolau","year":"2003","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.bjid.2014.01.008_bib0040","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.ijantimicag.2009.04.012","article-title":"The ARESC study: an international survey on the antimicrobial resistance of pathogens involved in uncomplicated urinary tract infections","volume":"34","author":"Schito","year":"2009","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.bjid.2014.01.008_bib0045","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1590\/S0074-02762006000700006","article-title":"Increased resistance to first-line agents among bacterial pathogens isolated from urinary tract infections in Latin America: time for local guidelines","volume":"101","author":"Andrade","year":"2006","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"10.1016\/j.bjid.2014.01.008_bib0050","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1128\/JCM.00376-11","article-title":"Nosocomial bloodstream infections in Brazilian hospitals: analysis of 2,563 cases from a prospective nationwide surveillance study","volume":"49","author":"Marra","year":"2011","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.bjid.2014.01.008_bib0055","series-title":"2013 Clinical and Laboratory Standards Institute performance standards for antimicrobial susceptibility testing: 23rd informational supplement (M100-S23)","author":"Clinical and Laboratory Standards Institute (CLSI)","year":"2013"},{"key":"10.1016\/j.bjid.2014.01.008_bib0060","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.1128\/AAC.39.11.2503","article-title":"Comparison of the bactericidal activities of ofloxacin and ciprofloxacin alone and in combination with ceftazidime and piperacillin against clinical strains of Pseudomonas","volume":"39","author":"Klepser","year":"1995","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bjid.2014.01.008_bib0065","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1002\/phar.1197","article-title":"Comparative pharmacokinetics, pharmacodynamics, and tolerability of ertapenem 1gram\/day administered as a rapid 5-minute infusion versus the standard 30-minute infusion in healthy adult volunteers","volume":"33","author":"Wiskirchen","year":"2013","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.bjid.2014.01.008_bib0070","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1128\/AAC.40.1.105","article-title":"Serum bactericidal activities and comparative pharmacokinetics of meropenem and imipenem\u2013cilastatin","volume":"40","author":"Dreetz","year":"1996","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bjid.2014.01.008_bib0075","doi-asserted-by":"crossref","first-page":"4718","DOI":"10.1128\/AAC.48.12.4718-4724.2004","article-title":"Pharmacodynamic profiling of piperacillin in the presence of tazobactam in patients through the use of population pharmacokinetic models and Monte Carlo","volume":"48","author":"Lodise","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bjid.2014.01.008_bib0080","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1093\/jac\/47.4.421","article-title":"The pharmacokinetics of once-daily dosing of ceftriaxone in critically ill patients","volume":"47","author":"Joynt","year":"2001","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.bjid.2014.01.008_bib0085","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.ijantimicag.2006.05.031","article-title":"Pharmacodynamic profiling of imipenem, meropenem and ertapenem against clinical isolates of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella spp. from Brazil","volume":"28","author":"Kiffer","year":"2006","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.bjid.2014.01.008_bib0090","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1592\/phco.27.3.333","article-title":"Pharmacodynamic target attainment of six beta-lactams and two fluoroquinolones against Pseudomonas aeruginosa, Acinetobacter baumannii, Escherichia coli, and Klebsiella species collected from United States intensive care units in 2004","volume":"27","author":"DeRyke","year":"2007","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.bjid.2014.01.008_bib0095","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/S0924-8579(02)00105-X","article-title":"Correlation between pharmacokinetic\/pharmacodynamic parameters and efficacy for antibiotics in the treatment of urinary tract infection","volume":"19","author":"Frimodt-M\u00f8ller","year":"2002","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.bjid.2014.01.008_bib0100","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1128\/AAC.06060-11","article-title":"In vitro antimicrobial resistance of urinary Escherichia coli isolates among U.S. outpatients from 2000 to 2010","volume":"56","author":"Sanchez","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bjid.2014.01.008_bib0105","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1093\/cid\/cir790","article-title":"\u03b2-Lactam\/\u03b2-lactam inhibitor combinations for the treatment of bacteremia due to extended-spectrum \u03b2-lactamase-producing Escherichia coli: a post hoc analysis of prospective cohorts","volume":"54","author":"Rodr\u00edguez-Ba\u00f1o","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.bjid.2014.01.008_bib0110","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S1413-8670(12)70291-X","article-title":"Sex, drugs, bugs, and age: rational selection of empirical therapy for outpatient urinary tract infection in an era of extensive antimicrobial resistance","volume":"16","author":"Rocha","year":"2012","journal-title":"Braz J Infect Dis"},{"key":"10.1016\/j.bjid.2014.01.008_bib0115","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1186\/1471-2334-11-286","article-title":"Pharmacodynamic evaluation of commonly prescribed oral antibiotics against respiratory bacterial pathogens","volume":"11","author":"Kiffer","year":"2011","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.bjid.2014.01.008_bib0120","doi-asserted-by":"crossref","first-page":"2765","DOI":"10.1016\/j.clinthera.2009.11.026","article-title":"Probability of pharmacodynamic target attainment with standard and prolonged-infusion antibiotic regimens for empiric therapy in adults with hospital-acquired pneumonia","volume":"31","author":"Kim","year":"2009","journal-title":"Clin Ther"},{"key":"10.1016\/j.bjid.2014.01.008_bib0125","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.ijantimicag.2010.02.004","article-title":"Microbiological outcome of complicated urinary tract infections treated with levofloxacin: a pharmacokinetic\/pharmacodynamic analysis","volume":"35","author":"Deguchi","year":"2010","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.bjid.2014.01.008_bib0140","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1111\/j.1365-2125.2011.04005.x","article-title":"Population pharmacokinetics of ceftriaxone in critically ill septic patients: a reappraisal","volume":"72","author":"Garot","year":"2011","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.bjid.2014.01.008_bib0145","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.diagmicrobio.2007.01.004","article-title":"Reevaluation of current susceptibility breakpoints for Gram-negative rods based on pharmacodynamic assessment","volume":"58","author":"DeRyke","year":"2007","journal-title":"Diagn Microbiol Infect Dis"}],"container-title":["The Brazilian Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1413867014000610?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1413867014000610?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,9]],"date-time":"2019-08-09T09:35:12Z","timestamp":1565343312000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1413867014000610"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9]]},"references-count":27,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2014,9]]}},"alternative-id":["S1413867014000610"],"URL":"https:\/\/doi.org\/10.1016\/j.bjid.2014.01.008","relation":{},"ISSN":["1413-8670"],"issn-type":[{"value":"1413-8670","type":"print"}],"subject":[],"published":{"date-parts":[[2014,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pharmacodynamic profiling of commonly prescribed antimicrobial drugs against Escherichia coli isolates from urinary tract","name":"articletitle","label":"Article Title"},{"value":"The Brazilian Journal of Infectious Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bjid.2014.01.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Editora Ltda.","name":"copyright","label":"Copyright"}]}}